SANUWAVE Health (SNWV) Capital Leases (2011 - 2025)
SANUWAVE Health's (SNWV) quarterly Capital Leases came in at $11000.0 in Q2 2025, down 83.33% on a QoQ basis from $66000.0 in Q4 2024.
SANUWAVE Health (SNWV) Capital Leases (2011 - 2025) Analysis & Trends
SANUWAVE Health (SNWV) has 7 years of Capital Leases data on file, last reported at $11000.0 in Q2 2025.
- On a quarterly basis, Capital Leases changed N/A year-over-year to $11000.0 in Q2 2025; TTM through Jun 2025 was $11000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $66000.0, changed N/A from the prior year.
- Capital Leases for Q2 2025 stood at $11000.0, down from $66000.0 in the prior quarter.
- Over the last five years, Capital Leases for SNWV reached as high as $66000.0 in Q4 2024 and fell as low as $11000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | SANUWAVE Health | 18.65 Mn | 7.87 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 11,000.00 |
| Dec 31, 2024 | 66,000.00 |
| Dec 31, 2020 | 233,766.00 |
| Sep 30, 2020 | 284,588.00 |
| Jun 30, 2020 | 333,771.00 |
| Mar 31, 2020 | 332,641.00 |
| Dec 31, 2019 | 271,240.00 |
| Dec 31, 2013 | 3,951.00 |
| Jun 30, 2013 | 1,343.00 |
| Mar 31, 2013 | 2,659.00 |
| Dec 31, 2012 | 3,951.00 |
| Sep 30, 2012 | 5,220.00 |
| Jun 30, 2012 | 6,464.00 |
| Mar 31, 2012 | 7,685.00 |
| Dec 31, 2011 | 8,884.00 |